{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T12:33:54Z","timestamp":1773491634547,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Health and Medical Research"},{"name":"Peter MacCallum Discovery Partner Fellowship"},{"name":"Victorian Cancer Council Colebatch"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ijrobp.2020.06.014","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T02:50:31Z","timestamp":1592362231000},"page":"941-949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Stereotactic Ablative Radiotherapy for \u2265T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)"],"prefix":"10.1016","volume":"108","author":[{"given":"Shankar","family":"Siva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohann J.M.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Staehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney J.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Ponsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irving D.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthilkumar","family":"Gandhidasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Swaminath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin S.","family":"Teh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon S.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Muacevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.06.014_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkz003","article-title":"Comparing long-term outcomes following radical and partial nephrectomy for ct1 renal cell carcinoma in young and healthy individuals","volume":"3","author":"Tan","year":"2019","journal-title":"JNCI Cancer Spectrum"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2010.12.013","article-title":"A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma","volume":"59","author":"Van Poppel","year":"2011","journal-title":"European Urol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eururo.2018.03.011","article-title":"Active surveillance for localized renal masses: Tumor growth, delayed intervention rates, and >5-yr clinical outcomes","volume":"74","author":"McIntosh","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.euf.2017.04.004","article-title":"Active surveillance for small renal masses: When less is more","volume":"2","author":"Ristau","year":"2016","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.juro.2012.09.042","article-title":"\u201cTrifecta\u201d in partial nephrectomy","volume":"189","author":"Hung","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/fon.16.2","article-title":"Consensus statement from the international radiosurgery oncology consortium for kidney for primary renal cell carcinoma","volume":"12","author":"Siva","year":"2016","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib7","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.31156","article-title":"Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the international radiosurgery oncology consortium for kidney (IROCK)","volume":"124","author":"Siva","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib8","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/JU.0000000000000111","article-title":"Stereotactic radiotherapy as a treatment option for renal tumors in the solitary kidney: A multicenter analysis from the IROCK","volume":"201","author":"Correa","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD guideline: Behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib12","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000353265","article-title":"Delayed progression to dialysis with early and intensive management of predialysis chronic kidney disease: A case-based approach","volume":"3","author":"Thomsen","year":"2013","journal-title":"Case Rep Nephrol Urol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization","volume":"164","author":"Keith","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1056\/NEJMcp0906797","article-title":"Clinical practice. Stage IV chronic kidney disease","volume":"362","author":"Abboud","year":"2010","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib16","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1464-410X.2008.08230.x","article-title":"Outcome of nephron-sparing surgery for t1b renal cell carcinoma","volume":"103","author":"Joniau","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib17","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.juro.2008.08.036","article-title":"Factors predicting renal functional outcome after partial nephrectomy","volume":"180","author":"Lane","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","article-title":"Chronic kidney disease after nephrectomy in patients with renal cortical tumours: A retrospective cohort study","volume":"7","author":"Huang","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1442-2042.2011.02765.x","article-title":"Postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: A comparison with radical nephrectomy","volume":"18","author":"Takagi","year":"2011","journal-title":"Int J Urol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.radonc.2016.01.027","article-title":"Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship","volume":"118","author":"Siva","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","article-title":"Glomerular hyperfiltration: Definitions, mechanisms and clinical implications","volume":"8","author":"Helal","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2016.08.060","article-title":"Partial nephrectomy versus radical nephrectomy for clinical t1b and t2 renal tumors: A systematic review and meta-analysis of comparative studies","volume":"71","author":"Mir","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2016.08.039","article-title":"Cryoablation versus partial nephrectomy for clinical t1b renal tumors: A matched group comparative analysis","volume":"71","author":"Caputo","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jvir.2011.09.008","article-title":"Complications following 573 percutaneous renal radiofrequency and cryoablation procedures","volume":"23","author":"Atwell","year":"2012","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jvir.2016.10.013","article-title":"Ct\u2013guided microwave ablation of 45 renal tumors: Analysis of procedure complexity utilizing a percutaneous renal ablation complexity scoring system","volume":"28","author":"Mansilla","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1148\/radiol.2016160592","article-title":"Effect of tumor complexity and technique on efficacy and complications after percutaneous microwave ablation of stage t1a renal cell carcinoma: A single-center, retrospective study","volume":"284","author":"Klapperich","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12032-017-0948-8","article-title":"Microwave ablation of malignant renal tumours: Intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications","volume":"34","author":"Ierardi","year":"2017","journal-title":"Med Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib28","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.crad.2017.03.029","article-title":"Percutaneous microwave ablation of renal cancers under CT guidance: Safety and efficacy with a 2-year follow-up","volume":"72","author":"Chan","year":"2017","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib29","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00270-016-1419-x","article-title":"Hemorrhagic complications of percutaneous cryoablation for renal tumors: Results from a 7-year prospective study","volume":"39","author":"Kakarala","year":"2016","journal-title":"Cardio Interv Radiol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1464-410X.2008.07735.x","article-title":"Risk factors associated with renal parenchymal fracture during laparoscopic cryoablation","volume":"102","author":"Hruby","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib31","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jvir.2010.04.022","article-title":"Ice ball fractures during percutaneous renal cryoablation: Risk factors and potential implications","volume":"21","author":"Schmit","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jamaoncol.2018.5543","article-title":"Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: The SURTIME randomized clinical trial","volume":"5","author":"Bex","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1803675","article-title":"Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma","volume":"379","author":"Mejean","year":"2018","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2010.09.012","article-title":"The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy","volume":"185","author":"Choueiri","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.clgc.2016.04.001","article-title":"Cytoreductive nephrectomy in metastatic renal cell carcinoma treated with targeted therapies: A systematic review with a meta-analysis","volume":"14","author":"Petrelli","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/COC.0000000000000329","article-title":"Stereotactic ablative radiotherapy (SABR) for large renal tumors: A retrospective case series evaluating clinical outcomes, toxicity, and technical considerations","volume":"41","author":"Correa","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib37","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1158\/1078-0432.CCR-16-2946","article-title":"A pilot study of stereotactic body radiation therapy combined with cytoreductive nephrectomy for metastatic renal cell carcinoma","volume":"23","author":"Singh","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2013.09.018","article-title":"Abscopal effects of radiation therapy: A clinical review for the radiobiologist","volume":"356","author":"Siva","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ctrv.2015.03.011","article-title":"The abscopal effect of local radiotherapy: Using immunotherapy to make a rare event clinically relevant","volume":"41","author":"Reynders","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2020.06.014_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/JTO.0b013e318292c55a","article-title":"Abscopal [corrected] effects after conventional and stereotactic lung irradiation of non-small-cell lung cancer","volume":"8","author":"Siva","year":"2013","journal-title":"J Thorac Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620312554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620312554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:55:33Z","timestamp":1759744533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620312554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0360301620312554"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.014","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Ablative Radiotherapy for \u2265T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}